Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

72.30
+0.82001.15%
Post-market: 72.00-0.2999-0.41%19:25 EDT
Volume:666.84K
Turnover:48.26M
Market Cap:7.62B
PE:64.87
High:73.08
Open:71.61
Low:71.60
Close:71.48
52wk High:117.33
52wk Low:33.34
Shares:105.37M
Float Shares:87.12M
Volume Ratio:0.55
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.11
EPS(LYR):1.35
ROE:21.70%
ROA:8.36%
PB:11.98
PE(LYR):53.41

Loading ...

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Apr 03

Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.

Filings Track
·
Apr 03

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Zacks
·
Apr 03

Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?

Zacks
·
Apr 02

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

Zacks
·
Apr 02

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

Zacks
·
Apr 01

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 01

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Zacks
·
Apr 01

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

Zacks
·
Apr 01

Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday?

Insider Monkey
·
Apr 01

Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

TIPRANKS
·
Apr 01

Small U.S. Stocks End Mixed As Corcept Therapeutics Lead, LZ Technology Holdings Lags

Dow Jones
·
Apr 01

Equity Markets Mixed Ahead of Tariff Announcements

MT Newswires Live
·
Apr 01

Why Is Corcept (CORT) Stock Soaring Today

StockStory
·
Apr 01

Corcept Therapeutics (NasdaqCM:CORT) Reports Positive Phase 3 Results Despite 8% Share Price Dip

Simply Wall St.
·
Apr 01

Top Midday Gainers

MT Newswires Live
·
Apr 01

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 01

Piper Sandler Raises Corcept Therapeutics' Price Target to $128 From $78, Maintains Overweight Rating

MT Newswires Live
·
Mar 31

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet

Benzinga
·
Mar 31

Corcept Therapeutics price target raised to $128 from $78 at Piper Sandler

TIPRANKS
·
Mar 31